Related Experiment Videos
Should antihypertensive therapies be given to patients with acute ischemic stroke?
1Duke Center for Cerebrovascular Disease, Stroke Policy Program, Duke University, North Carolina 27710, USA. golds004@mc.duke.edu
Insights
Managing high blood pressure in acute ischemic stroke is complex. Careful consideration of patient factors and medication properties is crucial to avoid harm and optimize recovery.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Hypertension is a significant risk factor for stroke.
- Elevated blood pressure is common in acute ischemic stroke patients.
- Managing hypertension during acute stroke is challenging due to potential autoregulation impairment.
Purpose of the Study:
- To clarify the complexities of hypertension management in acute ischemic stroke.
- To identify patient subgroups and conditions warranting blood pressure intervention.
- To guide the selection of appropriate antihypertensive agents for acute and long-term post-stroke care.
Main Methods:
- Review of existing literature and clinical guidelines on stroke and hypertension management.
- Analysis of the physiological effects of blood pressure lowering on cerebral autoregulation.
- Evaluation of pharmacological properties of antihypertensive agents relevant to acute stroke.
Main Results:
- Blood pressure lowering in acute ischemic stroke can be hazardous due to impaired cerebral autoregulation.
- Treatment is considered for specific cases: thrombolysis candidates, severe hypertension, or comorbid conditions (MI, aortic dissection, etc.).
- Certain drug classes (e.g., rapid-acting agents, cerebral vasodilators) require caution due to potential adverse effects like increased intracranial pressure.
Conclusions:
- Careful patient selection and drug choice are vital for managing hypertension in acute ischemic stroke.
- Long-term hypertension management post-stroke requires consideration of drug effects on neurological recovery.
- Avoiding precipitous blood pressure drops and agents that increase intracranial pressure is recommended in acute settings.
Abstract:
Hypertension is a major risk factor for stroke and many patients with acute stroke have elevated blood pressures. The management of hypertension in the setting of acute ischaemic stroke remains a source of confusion and controversy. Lowering blood pressure in this setting may be hazardous because of impaired cerebral autoregulation. Treatment may be considered in patients who are otherwise candidates for thrombolytic therapy, patients who have severe hypertension or patients who have specific concomitant medical conditions including acute myocardial infarction, aortic dissection, hypertensive encephalopathy, or severe left ventricular failure. In choosing an agent for acute treatment, drugs that can produce a precipitous decline in blood pressure (e.g. sublingual calcium antagonists) should be avoided. Drugs with the capacity to dilate cerebral vessels should be used with caution as they have the potential to increase intracranial pressure. Long term management of hypertension in poststroke patients is often required. The potential for certain classes of drugs (e.g. alpha2-adrenergic receptor agonists and alpha1-adrenergic receptor antagonists) to impair the recovery process should be considered when choosing an antihypertensive for treatment of these patients.